FDA Adverse Event Death Summary report: N

SOLETRA

MDR report key: 1161165 · Received September 15, 2008

Report

Report Number
2182207-2008-05750
Event Type
Death
Date Received
September 15, 2008
Report Date
August 19, 2008
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AR
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

JOURNAL REFERENCE: MERELLO M, TENCA E, LLORET SP, ET AL. PROSPECTIVE RANDOMIZED 1-YEAR FOLLOW-UP COMPARISON OF BILATERAL SUBTHALAMOTOMY VERSUS BILATERAL SUBTHALAMIC STIMULATION AND THE COMBINATION OF BOTH IN PARKINSON'S DISEASE PATIENTS: A PILOT STUDY. BR J NEUROSURG. 2008;22(3): 415-422. IT HAS BEEN SUGGESTED THAT POTENTIAL RISK OF HEMIBALLISMUS AFTER SUBTHALAMOTOMY MAKES DBS PREFERABLE TO ABLATION FOR IPD TREATMENT; HOWEVER, COST AND THE NEED FOR REGULAR ELECTRODE CONTROL HAVE ALSO BEEN OBSERVED AS DISADVANTAGES TO STIMULATION. THE OBJECTIVE WAS TO COMPARE EFFICACY AND SAFETY OF DIFFERENT SURGICAL APPROACHES TO STN, IN A PROSPECTIVE RANDOMIZED PILOT STUDY. SIXTEEN CONSECUTIVE IPD PATIENTS RANDOMIZED TO RECEIVE EITHER: BILATERAL STN-DBS (BS GROUP), BILATERAL SUBTHALAMOTOMY (BL GROUP), OR UNILATERAL SUBTHALAMOTOMY PLUS CONTRALATERAL STN-DBS IMPLANTATION (L/S GROUP), AND FOLLOWED FOR 12 MONTHS AFTER SURGERY. REPORTABLE EVENT: ONE PT IN THE BS GROUP PRESENTED A LARGE SUBCORTICAL BRAIN HAEMATOMA. A CANNULA FOR THE DBS CATHETER INTRODUCED, AT WHICH TIME THE PT SUDDENLY DEVELOPED A FACIAL DEVIATION, LOSS OF CONSCIOUSNESS AND PROGRESSIVE HEMIPLEGIA. THE CANNULA WAS REMOVED AND AN INTEROPERATIVE MRI SCAN PERFORMED CONFIRMING A THALAMIC HAEMATOMA. A FEW HRS LATER, CLINICAL DETERIORATION AND PROGRESSIVE WORSENING OF THE HAEMATOMA, CONFIRMED BY A NEW MRI SCAN, REQUIRED THE PT TO UNDERGO OPEN SURGERY FOR EVAL. THE PT DIED FROM CLINICAL COMPLICATIONS AFTER 20 DAYS IN INTENSIVE CARE. SEE MFG REPORT 2182207200805745.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SOLETRA MHY MEDTRONIC NEUROMODULATION 7426 NA

Patients

Seq Age Sex Outcome Treatment
1 Death EXTENSION MODEL UNK N=2| LEAD MODEL 3389 N=2| PROGRAMMER MODEL UNK N=1